Quarterly Report

Phio Pharmaceuticals Corp. Filed 2022-11-10 Acc 0001683168-22-007528

Documents 1

2023-05-11 10-Q Quarterly Report
2022-11-16 8-K Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
2022-11-16 PRE 14A Proxy Statement (Preliminary)
2022-11-16 4 Interim Executive Chairman bought 1 shares at $1,750.00 ($1,750)
2022-11-10 8-K Results of operations
2022-11-10 10-Q Quarterly Report
2022-08-11 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading phio_i10q-093022.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…